1. 2.The Cost Effectiveness of Alternative Types of Vascular access and the Economic Cost of ESRD. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995:139-157
2. Vascular access use in Europe and the United States: Results from the DOPPS;Pisoni;Kidney Int,2002
3. Superiority of autogenous arteriovenous hemodialysis access: Maintenance of function with fewer secondary interventions;Perera;Ann Vasc Surg,2004